Premium
Screening for prostate cancer with serum prostate‐specific antigen
Author(s) -
Davis John W.
Publication year - 2008
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.23933
Subject(s) - medicine , prostatectomy , prostate cancer , prostate specific antigen , prostate , cancer , urology , antigen , oncology , gynecology , immunology
Nguyen et al compared the cancer recurrence‐free survival after radical prostatectomy among 2 groups of men diagnosed with prostate cancer due to an elevated serum prostate‐specific antigen (PSA): 1) those whose initial screening PSA was abnormal and 2) those with a history of previous normal screening PSAs. The study found group 1 to have more adverse pathologic features and recurrence‐free survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom